VIRI: Virios Therapeutics, Inc. Stock

by  •  • Comments Off on VIRI: Virios Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 7.18
Enterprise Value ($M) 3.86
Book Value ($M) 3.81
Book Value / Share 0.20
Price / Book 1.89
NCAV ($M) 3.81
NCAV / Share 0.20
Price / NCAV 1.89

Profitability (mra)
Return on Invested Capital (ROIC) -1.33
Return on Assets (ROA) -0.78
Return on Equity (ROE) -0.69

Liquidity (mrq)
Quick Ratio 11.62
Current Ratio 11.62

Balance Sheet (mrq) ($M)
Current Assets 4.17
Assets 4.17
Liabilities 0.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -5.45
Net Income -5.30

Cash Flow Statement (mra) ($M)
Cash From Operations -4.87
Cash from Investing 0.00
Cash from Financing 1.16

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Corday Brian David 4.60 -32.95

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-08 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1
2024-03-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-10 32,167 14,078 228.49
2024-05-09 71,747 44,217 162.26
2024-05-08 54,416 8,100 671.80
2024-05-07 10,956 12,866 85.15
2024-05-06 1,995 9,389 21.25

(click for more detail)

Similar Companies
VCNX – Vaccinex, Inc. VERU – Veru Inc.
VINC – Vincerx Pharma, Inc. VKTX – Viking Therapeutics, Inc.
VRPX – Virpax Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io